Mapi Pharma Ltd., a late-stage clinical development biopharmaceutical company has signed a long term lease agreement at the Har-Hotzvim Hi-Tech Park in Jerusalem to establish a new sterile production plant for GA Depot injectable products. The 50,000 sq.-ft. plant was previously part of Omrix Biopharmaceuticals, Inc., a Johnson & Johnson Company, and was an FDA-approved facility. The new leased area will be used for commissioning a commercial scale production facility for GA Depot and is ...